Form 4: Omada Health Insider Sells Shares Under 10b5-1 Plan

Omada Health Chief Accounting Officer Craig Gracey sold 2,083 shares of common stock for $18 per share, totaling $37,494, under a pre-established 10b5-1 trading plan.

Summary

• Craig Gracey, Chief Accounting Officer at Omada Health, Inc., reported a transaction on June 22, 2026.
• The transaction involved the sale of 2,083 shares of common stock.
• The sale was executed at a price of $18 per share, resulting in a total transaction value of $37,494.
• These shares were sold under a Rule 10b5-1 trading plan adopted by Gracey on March 13, 2026.
• Following this transaction, Gracey beneficially owns 7,108 shares of Omada Health common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral. While it involves an insider selling shares, the transaction was conducted under a pre-arranged 10b5-1 plan, mitigating concerns about opportunistic trading.

Negatives

• Insider selling can sometimes be interpreted negatively by the market, although this sale was conducted under a pre-planned trading strategy.

Risks

• The primary risk associated with insider selling, even under a 10b5-1 plan, is the potential negative perception by the market regarding the insider's confidence in the company's future performance.

Future Outlook

The filing itself does not contain forward-looking statements or guidance. The transaction was executed under a pre-determined plan.

Industry Context

StockSavvy.ai notes that Form 4 filings, such as this one from Omada Health, are standard disclosures for insider transactions. The use of a Rule 10b5-1 plan is a common strategy for executives to sell shares without facing accusations of insider trading, as the plan is established when the executive does not possess material non-public information.

Stakeholder Impact

• Shareholders: May view insider selling with caution, though the 10b5-1 plan mitigates concerns about insider knowledge. The sale represents a small portion of the company's outstanding shares.
• Employees: Similar to shareholders, the impact is likely minimal given the planned nature of the sale.
• Management: Demonstrates adherence to regulatory requirements and responsible trading practices through the use of a 10b5-1 plan.

Next Steps

• Continued monitoring of insider transactions for any further sales or purchases that might indicate changes in management's outlook.

Key Dates

Keywords

Omada Health, OMDA, Form 4, Insider Trading, Stock Sale, 10b5-1 Plan, Chief Accounting Officer, Securities Exchange Act